CompoAtlas

Perles de peau Radiance, flaconnettes

Food supplement declared in France, declaration No 2016-7-44

Perles de peau Radiance, flaconnettes, from LABORATOIRES ARKOPHARMA, is a food supplement declared in France. Status: withdrawn from the market on 30 November 2019. Main ingredients: Ascophyllum nodosum 180 mg per day, Selenium, Vitamin C, Zinc, Collagène hydrolysé. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
not provided
Food business operator placing the product on the market
LABORATOIRES ARKOPHARMA
Status
Withdrawn from the market on 30 November 2019
Form
Autre : Flaconnettes
Daily dose
1 flaconnette
Directions for use
1 flaconnette par jour à boire, de préférence diluée dans un grand verre d'eau ou jus de fruits
Objectives stated by the manufacturer (these are not authorised claims)
Skin

Declaration 155768, procedure Article 16. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Ascophyllum nodosum (L.) Le JolisThalleExtrait sec aqueux180 mg

Other active ingredients

NamePer day
Collagène hydrolysénot declared
Acide hyaluroniquenot declared

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
sodium selenateSelenium255 µg50 µg
L-ascorbic acidVitamin Cno limit (insufficient data)180 mg
zinc gluconateZinc25 mg15 mg

Additives

E330, E202, E211, E955

Other ingredients

Eau purifiée

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Regulatory points

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Collagène hydrolysé
    Read the warning, when it applies and the studies cited

    Hydrolyzed Collagen

    Route of administration: Oral

    Cautions and warnings

    Condition of application: Joint pain.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.

    Applies to products providing more than 2.8 g hydrolyzed collagen, per day.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Shils et al. 2006; Goldman and Ausiello 2004).

    Sources cited by Health Canada (2)
    • Goldman L, Ausiello D, editors. Cecil Textbook of Medicine, Volume 1, 22nd edition. Philadelphia (PA): Saunders; 2004.
    • Shils ME, Shike M, Ross AC, Caballero B, Cousins RJ, editors. Modern Nutrition in Health and Disease, 10th edition. Philadelphia (PA): Lippincott Williams and Wilkins, 2006.

    Known adverse reactions

    When using this product you may experience gastrointestinal discomfort/disturbances (Moskowitz 2000).

    Sources cited by Health Canada (1)
    • Moskowitz RW. Role of collagen hydrolysate in bone and joint disease. Seminars in Arthritis and Rheumatism 2000;30(2):87-99. PubMed Randomised trial

    Health Canada monograph dated 28 March 2024

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Perles de peau Radiance, flaconnettes: composition and regulation”, https://compoatlas.com/en/supplements/products/155768-perles-de-peau-radiance-flaconnettes, updated 15 November 2026.

Enter to analyse, Shift+Enter for a new line